Mimetic Medicines
PrivateLast Round
Seed
Jan 2, 2024
Total Funding Raised
$3.6M
Company Overview
Mimetic Medicines operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Seed round in January 2024.
Mimetic Medicines is a biotechnology company that develops non-opioid therapeutic candidates for the treatment of chronic pain and neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mimetic Medicines Comparables
Compare Mimetic Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlphaNavi Pharma Inc. | 79% | |
| Latigo Biotherapeutics | 77% | |
| Algiax Pharmaceuticals | 76% |
For institutional investors. Book with your work email.
Mimetic Medicines Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Mimetic Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AgFunder | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 2, 2024
$3.6M round led by AgFunder
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 7, 2026
On Oct 7th '26, Mimetic Medicines, Inc., based in Massachusetts, is developing investigational long-acting SLiP candidates that aim to systemically disrupt the Nav1.8-Ank3 interaction and create non-opioid treatments for chronic neuropathic pain.
For institutional investors. Book with your work email.
Mimetic Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Mimetic Medicines's valuation, stock price, and market status.
Is Mimetic Medicines a public or private company?
Mimetic Medicines is a private company.
What is the current stock price of Mimetic Medicines?
Mimetic Medicines is a private company, so its shares have no public market price. Caplight tracks Mimetic Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Mimetic Medicines worth (valuation)?
Valuation information for Mimetic Medicines is not publicly available.
Can I buy Mimetic Medicines stock?
Mimetic Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Mimetic Medicines's last funding round?
Mimetic Medicines's most recent funding round was Seed on January 2, 2024.
Who are the main investors in Mimetic Medicines?
Key investors in Mimetic Medicines include AgFunder.
Will Mimetic Medicines IPO soon?
No public IPO plans have been announced for Mimetic Medicines.
How can I track Mimetic Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Mimetic Medicines's shares on secondary markets.